0000000000267586

AUTHOR

Ann Knoop

0000-0003-2898-1093

showing 2 related works from this author

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women

2014

INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set.METHODS: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR).RESULTS: Numbers of specific miRNAs detected in the samples ranged fro…

Circulating mirnaslcsh:MedicineEstrogen receptorBreast NeoplasmsBioinformaticsBiochemistryBreast cancerSurgical oncologymicroRNABreast TumorsBreast CancermedicineMedicine and Health SciencesBiomarkers TumorHumansPostoperative PeriodStage (cooking)lcsh:Scienceskin and connective tissue diseasesAgedNeoplasm StagingAged 80 and overMultidisciplinarybusiness.industrylcsh:RCarcinoma Ductal BreastCancerBiology and Life SciencesCancers and NeoplasmsMiddle Agedmedicine.diseasePostmenopauseCirculating MicroRNAMicroRNAsOncologyReceptors Estrogenlcsh:QFemalebusinessBiomarkersResearch ArticlePLoS ONE
researchProduct

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer:A case control study

2014

Introduction There are currently no highly sensitive and specific minimally invasive biomarkers for detection of early‐stage breast cancer. MicroRNAs (miRNAs) are present in the circulation and may be unique biomarkers for early diagnosis of human cancers. The aim of this study was to investigate the differential expression of miRNAs in the serum of breast cancer patients and healthy controls. Methods Global miRNA analysis was performed on serum from 48 patients with ER‐positive early‐stage breast cancer obtained at diagnosis (24 lymph node‐positive and 24 lymph node‐negative) and 24 age‐matched healthy controls using LNA‐based quantitative real‐time PCR (qRT‐PCR). A signature of miRNAs was…

Genetic MarkersOncologyCancer Researchmedicine.medical_specialtyEstrogen receptorBreast NeoplasmsBiologyReal-Time Polymerase Chain ReactionBioinformaticsSerum markersBreast cancerBreast cancerInternal medicinemicroRNABiomarkers TumorGeneticsmedicineHumansBreastStage (cooking)Lymph nodeResearch ArticlesAgedmiRNAReceiver operating characteristicGene Expression ProfilingCase-control studyGeneral MedicineMiddle Agedmedicine.diseaseGene Expression Regulation NeoplasticMicroRNAsCirculating MicroRNAmedicine.anatomical_structureReceptors EstrogenOncologyCase-Control StudiesMolecular MedicineFemaleMiRNAResearch Article
researchProduct